English
Insider transactions
EDGARBLUE BIRD CORPORATION
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 3 transactions, 1,050 shares
- Sum of shares × price per share: 62,476.5
- Open-market sales (code S)
- 7 transactions, 43,488 shares
- Sum of shares × price per share: 2,332,058.77
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–44 of 44
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 Filed 2026-09-18 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 62.40 | 249,600Derived: shares × price per share. Exact value 249600.00. | 35,011 | Direct (D) | No | — | Open filing 0002094766-26-000006 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-13 | Thau Daniel Mark Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 350 | 64.37 | 22,529.5Derived: shares × price per share. Exact value 22529.50. | 9,046 | Direct (D) | No | — | Open filing 0002047774-26-000007 Read from the filing’s XML Dispute this row |
| 2026-05-19 Filed 2026-05-20 | Thau Daniel Mark Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 300 | 65.09 | 19,527Derived: shares × price per share. Exact value 19527.00. | 8,696 | Direct (D) | No | F1
| Open filing 0002047774-26-000004 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-09 | Girardin Steve Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1 | — | — | 1 | Indirect (I) See footnote | No | F1, F2
| Open filing 0002127543-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-09 | Girardin Steve Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 2,297 | Direct (D) | No | F3, F4
| Open filing 0002127543-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-09 | Girardin Steve Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,702,180 | — | — | 2,702,180 | Indirect (I) See footnote | No | F1, F5
| Open filing 0002127543-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Hightower Edward T. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 6,396 | Direct (D) | No | F1, F2
| Open filing 0001894132-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Blaufuss Mark Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 10,334 | Direct (D) | No | F1, F2
| Open filing 0001625944-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Penn Kevin S. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 6,396 | Direct (D) | No | F1, F2
| Open filing 0001626076-26-000005 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Grimm Douglas J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 28,764 | Direct (D) | No | F1, F2
| Open filing 0001626219-26-000006 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Newman Simon J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 10,334 | Direct (D) | No | F1, F2
| Open filing 0001980199-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Fream Julie A Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 9,705 | Direct (D) | No | F1, F2
| Open filing 0001486034-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-01 Filed 2026-04-02 | Thau Daniel Mark Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,297 | 0 | — | 8,396 | Direct (D) | No | F1, F2
| Open filing 0002047774-26-000002 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-05 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 5,192 | 12.35 | 64,121.2Derived: shares × price per share. Exact value 64121.20. | 44,203 | Direct (D) | No | — | Open filing 0002094766-26-000003 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-05 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,192 | 58.54 | 303,939.68Derived: shares × price per share. Exact value 303939.68. | 39,011 | Direct (D) | No | F1
| Open filing 0002094766-26-000003 Read from the filing’s XML Dispute this row |
| 2026-03-04 Filed 2026-03-05 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 5,192 | 0 | — | 0 | Direct (D) | No | — | Open filing 0002094766-26-000003 Read from the filing’s XML Dispute this row |
| 2026-02-19 Filed 2026-02-20 | Radulescu Razvan Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,925 | 60.98 | 239,346.5Derived: shares × price per share. Exact value 239346.50. | 42,255 | Direct (D) | No | — | Open filing 0001884757-26-000004 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-17 | Radulescu Razvan Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,503 | 12.35 | 43,262.05Derived: shares × price per share. Exact value 43262.05. | 49,683 | Direct (D) | Yes | — | Open filing 0001884757-25-000037 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-17 | Radulescu Razvan Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,503 | 12.35 | 43,262.05Derived: shares × price per share. Exact value 43262.05. | 53,186 | Direct (D) | Yes | — | Open filing 0001884757-25-000037 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-17 | Radulescu Razvan Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,006 | 51.58 | 361,369.48Derived: shares × price per share. Exact value 361369.48. | 46,180 | Direct (D) | Yes | F1
| Open filing 0001884757-25-000037 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-17 | Radulescu Razvan Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,503 | 0 | — | 0 | Direct (D) | Yes | — | Open filing 0001884757-25-000037 Read from the filing’s XML Dispute this row |
| 2025-12-17 Filed 2025-12-17 | Radulescu Razvan Officer: Chief Financial Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 3,503 | 0 | — | 0 | Direct (D) | Yes | F2
| Open filing 0001884757-25-000037 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-16 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 549 | 50.36 | 27,647.64Derived: shares × price per share. Exact value 27647.64. | 39,011 | Direct (D) | No | F1
| Open filing 0002094766-25-000010 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-16 | Scartz Ted Officer: SVP General Counsel | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 626 | 50.36 | 31,525.36Derived: shares × price per share. Exact value 31525.36. | 59,910 | Direct (D) | No | F1
| Open filing 0001929771-25-000016 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-16 | Horlock Phil Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,040 | 50.50 | 355,520Derived: shares × price per share. Exact value 355520.00. | 233,726 | Direct (D) | No | — | Open filing 0001579477-25-000022 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-16 | Horlock Phil Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,341 | 50.35 | 419,969.35Derived: shares × price per share. Exact value 419969.35. | 225,385 | Direct (D) | No | — | Open filing 0001579477-25-000022 Read from the filing’s XML Dispute this row |
| 2025-12-12 Filed 2025-12-16 | Radulescu Razvan Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,907 | 50.36 | 146,396.52Derived: shares × price per share. Exact value 146396.52. | 46,180 | Direct (D) | No | F1
| Open filing 0001884757-25-000033 Read from the filing’s XML Dispute this row |
| 2025-12-10 Filed 2025-12-10 | Radulescu Razvan Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,984 | 50.39 | 402,313.76Derived: shares × price per share. Exact value 402313.76. | 49,087 | Direct (D) | Yes | F1
| Open filing 0001884757-25-000031 Read from the filing’s XML Dispute this row |
| 2025-12-06 Filed 2025-12-09 | Scartz Ted Officer: SVP General Counsel | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 881 | 51.27 | 45,168.87Derived: shares × price per share. Exact value 45168.87. | 60,536 | Direct (D) | No | F1
| Open filing 0001929771-25-000014 Read from the filing’s XML Dispute this row |
| 2025-12-06 Filed 2025-12-09 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 753 | 51.27 | 38,606.31Derived: shares × price per share. Exact value 38606.31. | 39,560 | Direct (D) | No | F1
| Open filing 0002094766-25-000007 Read from the filing’s XML Dispute this row |
| 2025-12-06 Filed 2025-12-09 | Radulescu Razvan Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 3,287 | 51.27 | 168,524.49Derived: shares × price per share. Exact value 168524.49. | 57,071 | Direct (D) | No | F1
| Open filing 0001884757-25-000026 Read from the filing’s XML Dispute this row |
| 2025-12-04 Filed 2025-12-05 | Thau Daniel Mark Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 400 | 51.05 | 20,420Derived: shares × price per share. Exact value 20420.00. | 6,099 | Direct (D) | No | — | Open filing 0002047774-25-000006 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Scartz Ted Officer: SVP General Counsel | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 820 | 50.70 | 41,574Derived: shares × price per share. Exact value 41574.00. | 47,949 | Direct (D) | No | F1
| Open filing 0001929771-25-000012 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Scartz Ted Officer: SVP General Counsel | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 5,387 | 0 | — | 53,336 | Direct (D) | No | F2, F3
| Open filing 0001929771-25-000012 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Scartz Ted Officer: SVP General Counsel | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 8,081 | 0 | — | 61,417 | Direct (D) | No | F2, F4
| Open filing 0001929771-25-000012 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Wyskiel John Director · Officer: President CEO | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 14,447 | 50.70 | 732,462.9Derived: shares × price per share. Exact value 732462.90. | 88,088 | Direct (D) | No | F1
| Open filing 0002055903-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Wyskiel John Director · Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,332 | 0 | — | 107,420 | Direct (D) | No | F2, F3
| Open filing 0002055903-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Wyskiel John Director · Officer: President CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 28,999 | 0 | — | 136,419 | Direct (D) | No | F2, F4
| Open filing 0002055903-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Radulescu Razvan Officer: Chief Financial Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 2,626 | 50.70 | 133,138.2Derived: shares × price per share. Exact value 133138.20. | 38,168 | Direct (D) | No | F1
| Open filing 0001884757-25-000024 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Radulescu Razvan Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 8,876 | 0 | — | 47,044 | Direct (D) | No | F2, F3
| Open filing 0001884757-25-000024 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Radulescu Razvan Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 13,314 | 0 | — | 60,358 | Direct (D) | No | F2, F4
| Open filing 0001884757-25-000024 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | FPayment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Disposed (D) | 780 | 50.70 | 39,546Derived: shares × price per share. Exact value 39546.00. | 30,056 | Direct (D) | No | F1
| Open filing 0002094766-25-000004 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,103 | 0 | — | 34,159 | Direct (D) | No | F2, F3
| Open filing 0002094766-25-000004 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Sanfrey Jeffrey Scott Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 6,154 | 0 | — | 40,313 | Direct (D) | No | F2, F4
| Open filing 0002094766-25-000004 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–6 of 6
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| IMC-Chicago, LLC Option: Call | 14,200 SH | 788,100 dollars | Higher by 3,700 Prior quarter: 10,500 | Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row |
| IMC-Chicago, LLC Option: Put | 4,500 SH | 249,750 dollars | Lower by 3,000 Prior quarter: 7,500 | Open filing 0001452861-26-000007 Filed 2026-11-05 Dispute this row |
| SIMPLEX TRADING, LLC Option: Call | 1,400 SH | 77,700 dollars | Higher by 600 Prior quarter: 800 | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| GROUP ONE TRADING LLC Option: Put | 200 SH | 11,100 dollars | Not in the prior quarter’s filings read | Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row |
| SIMPLEX TRADING, LLC Option: Put | 100 SH | 5,550 dollars | Not in the prior quarter’s filings read | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| GROUP ONE TRADING LLC Option: Call | 100 SH | 5,550 dollars | Lower by 3,700 Prior quarter: 3,800 | Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row |
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
Showing 1–1 of 1
| Member | Transaction date | Type | Amount | Owner | Report |
|---|---|---|---|---|---|
| Hon. Julie Johnson (TX32) | 2025-04-07 | Sale | $1,001 - $15,000 | JT | 2025-05-14 |
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Millennium Management LLC Common Stock, par value $0.0001 per share | 5.2 | 1,616,752.00 | 10/13/2026 Filed 2026-10-20 | SCHEDULE 13G | Open filing 0001104659-26-117499 Dispute this row |
| Millennium Group Management LLC Common Stock, par value $0.0001 per share | 5.2 | 1,616,752.00 | 10/13/2026 Filed 2026-10-20 | SCHEDULE 13G | Open filing 0001104659-26-117499 Dispute this row |
| Israel A. Englander Common Stock, par value $0.0001 per share | 5.2 | 1,616,752.00 | 10/13/2026 Filed 2026-10-20 | SCHEDULE 13G | Open filing 0001104659-26-117499 Dispute this row |
| FMR LLC COMMON STOCK | 11.5 | 3,635,853.08 | 09/30/2026 Filed 2026-11-05 | SCHEDULE 13G/AAmendment 8 | Open filing 0000315066-26-002707 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 11.5 | 3,635,853.08 | 09/30/2026 Filed 2026-11-05 | SCHEDULE 13G/AAmendment 8 | Open filing 0000315066-26-002707 Dispute this row |
| FMR LLC COMMON STOCK | 10.2 | 3,218,919.01 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G/AAmendment 7 | Open filing 0000315066-26-002297 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 10.2 | 3,218,919.01 | 08/31/2026 Filed 2026-09-08 | SCHEDULE 13G/AAmendment 7 | Open filing 0000315066-26-002297 Dispute this row |
| FMR LLC COMMON STOCK | 9.5 | 3,017,352.69 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G/AAmendment 6 | Open filing 0000315066-26-001955 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 9.5 | 3,017,352.69 | 06/30/2026 Filed 2026-08-06 | SCHEDULE 13G/AAmendment 6 | Open filing 0000315066-26-001955 Dispute this row |
| Groupe Autobus Girardin Ltee Common Stock, $0.0001 par value | 7.88 | 2,702,180.00 | 04/01/2026 Filed 2026-04-08 | SCHEDULE 13D | Open filing 0001104659-26-040979 Dispute this row |
| Steve Girardin Common Stock, $0.0001 par value | 1.94 | 625,825.00 | 04/01/2026 Filed 2026-04-08 | SCHEDULE 13D | Open filing 0001104659-26-040979 Dispute this row |
| Andre Girardin Common Stock, $0.0001 par value | 4.39 | 1,450,530.00 | 04/01/2026 Filed 2026-04-08 | SCHEDULE 13D | Open filing 0001104659-26-040979 Dispute this row |
| Dave Girardin Common Stock, $0.0001 par value | 1.94 | 625,825.00 | 04/01/2026 Filed 2026-04-08 | SCHEDULE 13D | Open filing 0001104659-26-040979 Dispute this row |
| FMR LLC COMMON STOCK | 8.0 | 2,541,382.50 | 03/31/2026 Filed 2026-05-06 | SCHEDULE 13G/AAmendment 5 | Open filing 0000315066-26-001152 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 8.0 | 2,541,382.50 | 03/31/2026 Filed 2026-05-06 | SCHEDULE 13G/AAmendment 5 | Open filing 0000315066-26-001152 Dispute this row |
| Vanguard Capital Management Common Stock | 5.14 | 1,624,951 | 03/31/2026 Filed 2026-04-29 | SCHEDULE 13G | Open filing 0002100119-26-000178 Dispute this row |
| The Vanguard Group Common Stock | 0 | 0 | 03/13/2026 Filed 2026-03-26 | SCHEDULE 13G/AAmendment 3 | Open filing 0000102909-26-000826 Dispute this row |
| American Century Investment Management, Inc. Common Stock | 5.6 | 1,792,771.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G | Open filing 0000052388-26-000053 Dispute this row |
| American Century Companies, Inc. Common Stock | 5.6 | 1,792,771.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G | Open filing 0000052388-26-000053 Dispute this row |
| Stowers Institute for Medical Research Common Stock | 5.6 | 1,792,771.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G | Open filing 0000052388-26-000053 Dispute this row |
| FMR LLC COMMON STOCK | 9.5 | 3,024,084.74 | 12/31/2025 Filed 2026-02-05 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-26-000373 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 9.5 | 3,024,084.74 | 12/31/2025 Filed 2026-02-05 | SCHEDULE 13G/AAmendment 4 | Open filing 0000315066-26-000373 Dispute this row |
| American Century Investment Management, Inc. Common Stock | 4.2 | 1,334,710.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000052388-25-000242 Dispute this row |
| American Century Companies, Inc. Common Stock | 4.2 | 1,334,710.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000052388-25-000242 Dispute this row |
| Stowers Institute for Medical Research Common Stock | 4.2 | 1,334,710.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000052388-25-000242 Dispute this row |
| FMR LLC COMMON STOCK | 12.3 | 3,887,180.93 | 09/30/2025 Filed 2025-11-05 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-25-002669 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 12.3 | 3,887,180.93 | 09/30/2025 Filed 2025-11-05 | SCHEDULE 13G/AAmendment 3 | Open filing 0000315066-25-002669 Dispute this row |
| The Vanguard Group Common Stock | 6 | 1,905,523 | 09/30/2025 Filed 2025-10-30 | SCHEDULE 13G/AAmendment 2 | Open filing 0000102909-25-000128 Dispute this row |
| American Century Investment Management, Inc. Common Stock | 7.2 | 2,267,131.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000052388-25-000184 Dispute this row |
| American Century Companies, Inc. Common Stock | 7.2 | 2,267,131.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000052388-25-000184 Dispute this row |
| Stowers Institute for Medical Research Common Stock | 7.2 | 2,267,131.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000052388-25-000184 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,638,030 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 55,117 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.